Download PDF
Thromb Haemost 1998; 79(04): 876-877
DOI: 10.1055/s-0037-1615082
Letters to the Editor
Schattauer GmbH

Expression of the Factor VII Activating Protease, Hepsin, in situ in Renal Cell Carcinoma

Leo R. Zacharski
1   From the VA Medical & Regional Office Center, White River Junction, Vermont
2   From the Departments of Medicine, New Hampshire, USA
,
Deborah L. Ornstein
1   From the VA Medical & Regional Office Center, White River Junction, Vermont
2   From the Departments of Medicine, New Hampshire, USA
,
Vincent A. Memoli
3   From the Pathology, Dartmouth Medical School, Hanover, New Hampshire, USA
,
Sandra M. Rousseau
1   From the VA Medical & Regional Office Center, White River Junction, Vermont
,
Walter Kisiel
4   From the Department of Pathology, University of New Mexico School of Medicine, Albuquerque, N.M.
› Author Affiliations
Further Information

Publication History

Received 01 May 1997

Accepted after resubmission 21 November 1997

Publication Date:
07 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Sem Thromb Hemost 1992; 18: 104-16.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Costantini V, Zacharski LR. Fibrin and cancer. Thromb Haemost 1993; 69: 406-14.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Zacharski LR, Dunwiddie C, Nutt EM, Hunt J, Memoli VA. Cellular localization of activated factor X by a Xa-specific probe. Thromb Haemost 1991; 65: 545-48.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Zacharski LR, Morain WD, Schlaeppi J-M, Memoli VA, Rousseau SM. Cellular localization of enzymatically active thrombin in intact human tissue by hirudin binding. Thromb Haemost 1995; 73: 793-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Zacharski LR, Memoli VA, Rousseau SM. Cancer-coagulation interaction in situ in renal cell carcinoma. Blood 1986; 68: 394-9.
    PubMedGoogle Scholar
  • 6 Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM, Stump DC. Fibrinogen-fibrin transformation in situ in renal cell carcinoma. Anticancer Research 1990; 10: 579-582.
    PubMedGoogle Scholar
  • 7 Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SA, Stump DC. Malignant melanoma: interaction with coagulation and fibrinolysis pathways in situ . Am J Clin Pathol 1990; 93: 516-21.
    CrossrefPubMedGoogle Scholar
  • 8 Zacharski LR, Ornstein DL, Memoli VA, Kisiel W, Rousseau SM. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Nat’l Cancer Inst 1993; 85: 1225-30.
    PubMedGoogle Scholar
  • 9 Leytus SP, Loeb KR, Hagen FS, Kurachi K, Davie EW. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochem 1988; 27: 1067-74.
    CrossrefPubMedGoogle Scholar
  • 10 Kurachi K, Torres-Rosado A, Tsuji A. Hepsin. Methods Enzymol 1994; 244: 100-14.
    PubMedGoogle Scholar
  • 11 Tsuji A, Torres-Rosado A, Arai T, Chou SH, Kurachi K. Characterization of hepsin, a membrane bound protease. Biomed biochim acta 1991; 50: 791-3.
    PubMedGoogle Scholar
  • 12 Tsuji A, Torres-Rosado A, Arai T, Lebeau MM, Lemons RS, Chou SH, Kurachi K. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem 1991; 266: 16 948-53.
    PubMedGoogle Scholar
  • 13 Kazama Y, Hamamoto T, Foster DC, Kisiel W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 1995; 270: 66-72.
    CrossrefPubMedGoogle Scholar
  • 14 Torres-Rosado A, O’Shea KS, Tsuji A, Chou SH, Kurachi K. Hepsin, a putative cell- surface serine protease, is required for mammalian cell growth. Proc Nat’l Acad Sci 1993; 90: 7181-5.
    PubMedGoogle Scholar
  • 15 Zacharski LR, Donati MB, Rickles FR. Registry of clinical trials of antithrombotic drugs in cancer: second report. Thromb Haemost 1993; 70: 357-60.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Lebeau B, Chastang C, Brechot J-M, Capron F, Dautzenberg B, Delaisements C, Mornet M, Brun J, Hurdebourcq J-P, Lemarie E. Subcutaneous heparin treatment increases survival in small cell lung cancer. Cancer 1994; 74: 38-45.
    CrossrefPubMedGoogle Scholar